You are here

Article Text

Article menu
Download PDFPDF
Orthopaedics
Malignant giant cell tumour of distal ulna
  1. Sandeep Kumar Yadav1,
  2. Rajesh Kumar Rajnish2,
  3. Vimal Prakash1 and
  4. Aasma Nalwa3
  1. 1Orthopedics, All India Institute of Medical Sciences, Jodhpur, India
  2. 2Orthopaedics, Post Graduate Institute of Medical Education and Research, Chandigarh, India
  3. 3Pathology, All India Institute of Medical Sciences, Jodhpur, India
  1. Correspondence to Dr Vimal Prakash; vimalprakash.1995{at}gmail.com

Abstract

Giant cell tumour (GCT) accounts for 5% of all primary bone tumours. GCT in the distal third of ulna is quite rare. We present a case of recurrent GCT in distal third of ulna with malignant features involving tenosynovium. The case was treated by wide resection of tumour and on follow up, patient recovered well with no evidence of further recurrence. Considering the features, according to the literature reviewed, is the first case of its type.

  • Orthopaedics
  • Oncology
  • Pathology

https://doi.org/10.1136/bcr-2023-258047

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors The following authors were responsible for drafting of the text, sourcing and editing of clinical images, investigation results, drawing original diagrams and algorithms, and critical revision for important intellectual content: SKY, RKR, VP and AN. The following authors gave final approval of the manuscript: SKY.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; externally peer reviewed.